ARCHIVES

DCCR Free Up $5 Million; New Policy Limits Core Support

This article is from The Cancer Letter archive.

Vol. 02 No. 45 | November 5, 1976

Download PDF Visit The Full Archive

Related Articles

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

NCI FY 1991 Operating Budget Outlined In Chart

December 7, 1990

Wyden Plans Bill To Induce Drug Firms to conduct Trials

October 29, 1993

Community-Based Program Final Planning Review In August, October

August 6, 1976

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

M.D. Anderson Breast Cancer Studies Promising NEJM Publishes Bonadnna Report

February 27, 1976